文献速递产科母胎医学

实施围产期质量协作全州倡议改善产科阿片类药物使用障碍的诊疗与结局

Implementation of perinatal quality collaborative statewide initiative improves obstetrical opioid use disorder care and outcomes.
PubMed 文献 · Am J Obstet Gynecol · 2024-04-19

伊利诺伊州围产期质量协作实施「受阿片类药物影响的母婴-产科」质量改进倡议,采用前瞻性队列设计,91家医院报告2018年7月至2020年12月分娩的2095例阿片类药物使用障碍患者月度关键指标。倡议期间接受药物辅助治疗率从41%升至78%,康复治疗服务率从48%升至67%;产前接受康复治疗服务及同时接受康复治疗与药物辅助治疗均与早产几率降低相关。倡议首季度黑人患者链接药物辅助治疗率低于白人患者(23% vs 48%),后所有患者药物辅助治疗率均上升,黑人患者改善最大,两种族链接率均>70%,差距缩小。

要点

  • 倡议期间药物辅助治疗率从41%升至78%,康复治疗服务率从48%升至67%。
  • 产前接受康复治疗服务与早产几率降低相关(aOR 0.67,95%CI 0.50-0.91)。
  • 产前同时接受康复治疗与药物辅助治疗与早产几率降低相关(aOR 0.49,95%CI 0.31-0.75)。

核心结论

  • 「受阿片类药物影响的母婴-产科」倡议与伊利诺伊州各医院妊娠患者阿片类药物使用障碍优化诊疗的改善相关。
  • 倡议期间阿片类药物使用障碍诊疗中的种族差异缩小。
  • 作者认为优化阿片类药物使用障碍诊疗可改善妊娠结局并缩小持续存在的种族差距。

研究设计与样本

  • 采用前瞻性队列设计,医院按月报告2018年7月至2020年12月分娩的所有阿片类药物使用障碍患者的关键指标。
  • 伊利诺伊州围产期质量协作提供协作学习机会、快速响应数据和质量改进支持。
  • 共91家医院提交2095例妊娠阿片类药物使用障碍患者的数据。
  • 采用广义线性混合效应回归模型评估优化诊疗的改善及其与早产等结局的关联。

主要发现

  • 主要结局:倡议期间接受药物辅助治疗率从41%升至78%,接受康复治疗服务率从48%升至67%。
  • 次要结局:产前接受康复治疗服务与早产几率降低相关(aOR 0.67,95%CI 0.50-0.91)。
  • 产前同时接受康复治疗服务和药物辅助治疗与早产几率降低相关(aOR 0.49,95%CI 0.31-0.75)。
  • 倡议首季度黑人患者链接药物辅助治疗率低于白人患者(23% vs 48%)。
  • 倡议期间所有患者药物辅助治疗率均上升,黑人患者改善最大,两种族链接率均>70%,差距缩小。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Maternal deaths resulting from opioid use disorder have been increasing across the United States. Opioid use disorder among pregnant persons is associated with adverse pregnancy outcomes, including preterm birth, along with racial disparities in optimal opioid use disorder care. OBJECTIVE: This study aimed to evaluate whether the Illinois Perinatal Quality Collaborative implementation of the Mothers and Newborns affected by Opioids - Obstetric quality improvement initiative was associated with improvement in opioid use disorder identification, provision of optimal opioid use disorder care for birthing patients, and reduction in racial gaps in optimal opioid use disorder care. STUDY DESIGN: Using a prospective cohort design, hospitals reported monthly key measures for all patients with opioid use disorder at delivery between July 2018 and December 2020. The Illinois Perinatal Quality Collaborative facilitates collaborative learning opportunities, rapid response data, and quality improvement support. Generalized linear mixed-effects regression models were used to evaluate improvement in optimal opioid use disorder care, including increases in linkages to medication-assisted treatment, recovery treatment services, and naloxone counseling across time, and to determine whether optimal opioid use disorder care was associated with positive outcomes, such as lower odds of preterm birth. RESULTS: A total of 91 hospitals submitted data on 2095 pregnant persons with opioid use disorder. For the primary outcomes, the rates of patients receiving medication-assisted treatment and recovery treatment services improved across the initiative from 41% to 78% and 48% to 67%, respectively. For the secondary outcomes, the receipt of recovery treatment services and both recovery treatment services and medication-assisted treatment provided prenatally before delivery admission was associated with lower odds of preterm birth (adjusted odds ratio: 0.67 [95% confidence interval, 0.50-0.91] and 0.49 [95% confidence interval, 0.31-0.75], respectively). During the first quarter of the initiative, Black patients with opioid use disorder were less likely to be linked to medication-assisted treatment than White patients (23% vs 48%, respectively); however, an increase in medication-assisted treatment rates across the initiative occurred for all patients, with the greatest improvement for Black patients with an associated reduction in this disparity gap with >70% of both Black and White patients linked to medication-assisted treatment. CONCLUSION: The Mothers and Newborns affected by Opioids - Obstetric initiative was associated with improvement in optimal opioid use disorder care for pregnant patients across Illinois hospitals, additionally racial disparities in opioid use disorder care was reduced across the initiative. Our findings implicate how optimal opioid use disorder care can improve pregnancy outcomes and close persistent racial gaps for pregnant individuals with opioid use disorder.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lee King PA, Lee S, Weiss D, et al. Implementation of perinatal quality collaborative statewide initiative improves obstetrical opioid use disorder care and outcomes. Am J Obstet Gynecol. 2024. PMID: 38642696. doi:10.1016/j.ajog.2024.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。